Antimicrobial resistance

Global database for Antimicrobial Resistance Country Self-Assessment

WHO, FAO and OIE launches second round of results of AMR country self-assessment survey. Status of countries regarding the actions taken to implement the global action plan to address antimicrobial resistance is now available in an open access global tripartite database. All responses to the country self-assessment questionnaire sent out in 2016 and 2017 can be found in the database with answers visualized through maps and in table form. This year, WHO, FAO and OIE have also published an analysis report of the country responses.

New WHO guidelines on use of medically important antimicrobials in food-producing animals

The new WHO recommendations aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their unnecessary use in animals. “A lack of effective antibiotics is as serious as a security threat as a sudden and deadly disease outbreak”, says Dr Tedros Adhanom Ghebreyesus, Director-General of WHO.

Call for comments on a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform

DEADLINE: 22 December 2017 The World Health Organization is partnering with Médecins Sans Frontières (MSF) and the Foundation for Innovative New Diagnostics (FIND) to develop a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform. This platform will help better diagnose the millions of people presenting with severe febrile illness without a known source in low- and middle-income countries.

A pharmacist holds a box of medicines to a client as other two boxes lay on the counter

New WHO report confirms world is running out of antibiotics

19 September 2017 - A new WHO report finds that very few antibiotics currently in development address the serious and growing threat of antimicrobial resistance. The report shows a lack of potential treatment options for drug-resistant tuberculosis and 12 other classes of priority pathogens identified by WHO. Tuberculosis is responsible for about 250 000 deaths a year and some of the other pathogens, such as GRAM-negatives, can kill patients in just a few days due to the lack of treatment options.

WHO/TDR /Andy Craggs
Visual of gonorrhoea virus

Antibiotic-resistant gonorrhoea on the rise, new drugs needed

7 July 2017 – Data from 77 countries show that antibiotic resistance is making gonorrhoea – a common sexually-transmitted infection – more difficult, and sometimes impossible, to treat. Some countries – particularly high-income ones, where surveillance is best – are finding cases of the infection that are untreatable by all known antibiotics. These cases may just be the tip of the iceberg, as gonorrhoea is more common in lower-income countries.


Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.

Resources and publications

Join our online Community of Practice

Are you developing/implementing a national action plan to address antimicrobial resistance? Would you welcome an opportunity for informal peer-to-peer discussions and/or access to prompt technical advice for operational challenges? The Community of practice holds a library of resources, from many different stakeholders, on a range of topics relevant to national action plans

Resistance in disease and areas

Blood test of a newborn baby, Hospital No 9, Moscow, Russia.

Call for consultants/proposals

There are currently no calls for a consultant. Please check the link below for more details when available.

Social media

Contact information:

Antimicrobial Resistance Secretariat ¦ World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland ¦ Email: